NSC-639829
NSC-639829 is a Benzoylphenylurea (BPU) analogue which has antitumor activity. NSC-639829 is promising for research of refractory metastatic cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 134742-19-1
- Formel: C21H20BrN5O3
- Molecular Weight:470.32
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| ASPC1 | IC50 |
0.85 μM
Compound: 1
|
Cytotoxicity against human ASPC1 cell line by MTT assay
Cytotoxicity against human ASPC1 cell line by MTT assay
|
[PMID: 16570932] |
| CWR22R | IC50 |
1 μM
Compound: 1
|
Cytotoxicity against human CWR22R cell line by MTT assay
Cytotoxicity against human CWR22R cell line by MTT assay
|
[PMID: 16570932] |
| Hs 766 | IC50 |
1 μM
Compound: 1
|
Cytotoxicity against human HS766 cell line by MTT assay
Cytotoxicity against human HS766 cell line by MTT assay
|
[PMID: 16570932] |
| HuCCT-1 | IC50 |
1 μM
Compound: 11
|
Inhibitory concentration of compound against growth of human HuCCT-1 cell line
Inhibitory concentration of compound against growth of human HuCCT-1 cell line
|
[PMID: 15081011] |
| LAPC4 | IC50 |
0.25 μM
Compound: 1
|
Cytotoxicity against human LAPC4 cell line by MTT assay
Cytotoxicity against human LAPC4 cell line by MTT assay
|
[PMID: 16570932] |
| LNCaP | IC50 |
0.5 μM
Compound: 1
|
Cytotoxicity against human LnCaP cell line by MTT assay
Cytotoxicity against human LnCaP cell line by MTT assay
|
[PMID: 16570932] |
| MIA PaCa-2 | IC50 |
0.85 μM
Compound: 1
|
Cytotoxicity against human Miapaca2 cell line by MTT assay
Cytotoxicity against human Miapaca2 cell line by MTT assay
|
[PMID: 16570932] |
| PANC-1 | IC50 |
0.7 μM
Compound: 1
|
Cytotoxicity against human Panc1 cell line by MTT assay
Cytotoxicity against human Panc1 cell line by MTT assay
|
[PMID: 16570932] |
| Panc1005 | IC50 |
5 μM
Compound: 1
|
Cytotoxicity against human Panc1005 cell line by MTT assay
Cytotoxicity against human Panc1005 cell line by MTT assay
|
[PMID: 16570932] |
| Panc203 | IC50 |
0.95 μM
Compound: 1
|
Cytotoxicity against human Panc203 cell line by MTT assay
Cytotoxicity against human Panc203 cell line by MTT assay
|
[PMID: 16570932] |
| Panc430 | IC50 |
0.8 μM
Compound: 1
|
Cytotoxicity against human Panc430 cell line by MTT assay
Cytotoxicity against human Panc430 cell line by MTT assay
|
[PMID: 16570932] |
Chemical Information
-
CAS. Nr. 134742-19-1
-
Molecular Weight 470.32
-
Formel C21H20BrN5O3
-
SMILES
O=C(NC1=CC=C(C(C)=C1)OC2=NC=C(C=N2)Br)NC(C3=C(N(C)C)C=CC=C3)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)